In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI
- 31 December 1997
- journal article
- research article
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 15 (10), 1177-1186
- https://doi.org/10.1016/s0730-725x(97)00182-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy: Zonal and age‐related differencesMagnetic Resonance in Medicine, 1996
- Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.Radiology, 1996
- Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: Detection via localized proton spectroscopyUrology, 1995
- Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical studyMagnetic Resonance in Medicine, 1993
- Localized proton MR spectroscopy of citrate in vitro and of the human prostate in vivo at 1.5 TMagnetic Resonance in Medicine, 1993
- Concepts of citrate production and secretion by prostate 1. Metabolic relationshipsThe Prostate, 1991
- Prostatic carcinoma and benign prostatic hyperplasia: MR imaging with histopathologic correlation.Radiology, 1989
- Prostate epithelial cells utilize glucose and aspartate as the carbon sources for net citrate productionThe Prostate, 1989
- In vivo estimation of relaxation processes in benign hyperplasia and carcinoma of the prostate gland by magnetic resonance imagingMagnetic Resonance Imaging, 1987
- Prostatic carcinoma and benign prostatic hyperplasia: inability of MR imaging to distinguish between the two diseases.Radiology, 1986